genia tagger: 287('phospho-stat3', 4)
('cells\\.', 30)
('-aaagaccacccggactacaa-', 2)
('tcr', 18)
('cohorts\\.', 2)
('cytometry', 2)
('pkc', 87)
('lymphoblastoid', 2)
('human', 26)
('hla-a2-fitc', 2)
('differentiation', 2)
('visceral', 28)
('uacc1273ev', 26)
('proteases', 2)
('cytokines', 2)
('-tubulin', 2)
('igg', 10)
('27', 84)
('20', 24)
('22', 4)
('23', 20)
('pcr', 10)
('\\?', 156)
('stained', 40)
('\\:', 64)
('uacc903', 28)
('untreated', 12)
('0', 474)
('\\%', 98)
('spei', 2)
('lymphocytes', 7)
('5', 785)
('maryland', 4)
('nci-', 4)
('5a', 583)
('\\(', 552)
('\\)', 622)
('murine', 6)
('siah2\\/apc', 2)
('release\\.', 4)
('phospho-stat3tyr705', 2)
('silv', 5)
('rna', 67)
('dc', 11)
('2', 329)
('antigen-specific', 2)
('cttcagagagaggaagccga', 2)
('cells-1', 1)
('pax3\\.', 4)
('gp75', 1)
('recombinant', 6)
('anti-mouse', 4)
('irb', 2)
('secondary', 2)
('lineage', 1)
('mart-1', 286)
('pbs', 14)
('n\\=10', 4)
('did', 9)
('uacc647', 18)
('16', 92)
('proteins', 2)
('l', 3539)
('specific', 31)
('t-lymphocytes', 2)
('immunosuppressive', 8)
('t', 7556)
('-3', 18)
('-gagctgaagcattgaagcaa', 2)
('lung', 16)
('ifn', 8)
('higher', 20)
('cells', 415)
('el4', 6)
('capped', 10)
('4\xe2\x80\x937', 2)
('antigen', 74)
('gfp', 8)
('ncbi\xe2\x80\x99s', 2)
('potent', 5)
('supplementary', 44)
('tyrosinase', 1)
('fibronectin', 6)
('5000', 2)
('non-canonical', 2)
('hla-a2', 8)
('nevi', 22)
('targets', 13)
('hla', 12)
('medium\\.', 2)
('residue', 4)
('tumor-infiltrating', 1)
('\\/a64', 6)
('icn', 2)
('factors', 3)
('mart1', 2)
('30gy', 4)
('t-cells', 38)
('gp100-specific', 4)
('cell', 489)
('3', 487)
('serine727', 6)
('vimentin', 8)
('smh', 2)
('monolayer\\.', 4)
('melanoma\xe2\x80\x93associated', 1)
('isoforms', 2)
('ifa', 2)
('24', 18)
('-ccatctgtgcagcaaacaac-', 2)
('mrna', 12)
('lymphocyte', 8)
('genes', 3)
('flow', 2)
('expression\\.', 26)
('wnt5a-low', 27)
('pkc-low', 2)
('metastatic', 40)
('plasmid', 8)
('mitf', 41)
('g\\/ml', 20)
('table', 18)
('uacc1273', 50)
('39', 6)
('38', 2)
('stat3', 147)
('reverse', 18)
('kiss-1', 1)
('tumor-associated', 5)
('30', 24)
('\\/sup', 4)
('wnt5a-high', 30)
('metastases\\.', 16)
('tumor', 48)
('\\>', 12)
('janus', 2)
('po4-pkc', 14)
('gp10025\xe2\x80\x9333', 4)
('matrix-metalloproteinases', 2)
('activation\\.', 12)
('irradiated', 4)
('ctl', 11)
('gene', 29)
('antibody', 16)
('gamma', 4)
('tyrp-1', 2)
('interferon', 8)
('6', 219)
('igg-fitc', 4)
('28', 18)
('rwnt5a-treated', 14)
('primary', 28)
('highly', 16)
('-cgctggctcttaaggtgaat-3', 2)
('anti-cd3', 2)
('receptor', 10)
('attccactttgcgttcaagg', 2)
('-ttgccgaagtcgatgtga-3', 2)
('sentinel', 4)
('melanosomal', 27)
('pulmonary', 2)
('ct', 378)
('calculation', 2)
('4\\\xc2\\\xb0c\\.', 2)
('much', 10)
('il10', 2)
('positive', 46)
('negative', 28)
('cultured', 24)
('1a', 4)
('t2', 10)
('t-cell', 66)
('kinases', 2)
('pbs-t', 2)
('tail-vein', 4)
('cultures', 4)
('splenocytes', 4)
('monoclonal', 2)
('low', 90)
('flat', 6)
('proliferative', 2)
('gp100-pulsed', 4)
('epsilon', 2)
('tap', 2)
('factor', 11)
('-taagcccaggagttgctttg-', 2)
('antigens', 59)
('ivt', 4)
('wnt', 579)
('\\/', 78)
('90', 32)
('line', 31)
('thyrocytes', 2)
('mart\\-1\\.', 25)
('cytotoxic', 1)
('b16', 74)
('target', 22)
('biopolymer', 2)
('culture', 34)
('19', 10)
('isolation', 4)
('mo', 257)
('4\\.', 4)
('43', 6)
('rpmi', 6)
('2\xc3\x97105', 8)
('r', 4984)
('vegf', 4)
('cdna', 2)
('assays', 28)
('metastases', 122)
('sirna', 31)
('pkc-high', 2)
('tyrp1', 10)
('cd8-pe', 2)
('associated', 17)
('figure', 164)
('sox10', 12)
('cd44', 10)
('metastasis', 20)
('laboratory\\.', 4)
('cd8', 24)
('uacc-1273ev', 2)
('rat', 110)
('-gggaccatggagtggtagc-', 2)
('dendritic', 2)
('plate\\.', 2)
('protein', 7)
('b', 956)
('cohort', 46)
('melanoma', 162)
('downstream', 1)
('socs3', 4)
('pax', 46)
('transcription', 26)
('b16-f10', 2)
('45', 10)
('-gcagagaggctgtgctccta-3', 2)
('realtime', 2)
('il-10', 2)
('il-6r', 2)
('1', 824)
('lymph', 42)
('biotinylated', 2)
('subcutaneous', 18)
('interferon-', 4)
('figures', 6)
('tarp', 4)
('melanocytic', 2)
('wnt5a-positive', 2)
('node', 30)
('200', 12)
('rhodamine-tagged', 2)
('rwnt5a', 116)
('cytokine', 6)
('m93-047', 12)
('ctls', 2)
('il-6', 20)
('il6', 6)
('not\\.', 2)
('bottom', 6)
('il-2', 4)
('1b', 4)
('sfm', 2)
('stat3\\.', 2)
('70', 6)
('96-well', 8)
('class', 4)
('-catenin', 4)
('a', 7402)
('antibodies', 8)
('primers', 4)
('s\\.e\\.m', 4)
('i', 5499)
('mel526', 8)
('gp100', 59)
('lines', 18)
('cd8\\+', 16)
('analysis', 21)
('electroporated', 8)
('pax3', 44)
('fixing', 2)
('wnt5a', 577)
('1000', 4)
('4b', 8)
('44', 22)
('anti-cd28', 2)


spacy + metamap: 687('lymphatic', 4)
('positive control', 6)
('scratch', 10)
('lack', 2)
('2 5', 2)
('dish', 4)
('primer', 4)
('cytokines', 2)
('animal facility', 2)
('inverse', 13)
('number', 20)
('tx', 4)
('pretreatment', 2)
('young', 2)
('lower', 15)
('foster', 2)
('sentinel lymph node', 2)
('sterile water', 2)
('maryland', 4)
('presentation', 10)
('endogenous', 4)
('cdna', 2)
('confirmation', 2)
('melanoma antigens', 2)
('downstream', 1)
('very', 11)
('activation', 66)
('pigment', 16)
('pathologist', 2)
('gp75', 1)
('difference', 6)
('continued', 4)
('condition', 2)
('cultured cells', 4)
('\\%\\ positive', 2)
('pbs', 14)
('level', 55)
('chains', 6)
('solution', 2)
('phosphorylation', 19)
('t-lymphocytes', 2)
('vector', 6)
('standard deviation', 2)
('cell lines', 10)
('serum-free media', 2)
('triplicate', 14)
('trend', 6)
('antigen', 74)
('fold', 2)
('microarray analysis', 2)
('enhancement', 1)
('further', 21)
('sterile', 4)
('elisa', 8)
('residue', 4)
('cutaneous', 20)
('abundant', 2)
('section', 4)
('rhodamine', 4)
('interferon gamma', 4)
('experiment', 11)
('sup', 92)
('3b', 4)
('contrast', 6)
('3d', 4)
('injections', 6)
('cohorts', 20)
('proliferation', 1)
('national cancer institute', 6)
('genes', 3)
('ulceration', 4)
('hours', 24)
('groups', 6)
('others', 4)
('transcription factors', 3)
('strong', 12)
('cell motility', 6)
('great', 16)
('institute', 14)
('study', 12)
('larger', 2)
('guide', 4)
('products', 2)
('ctl', 11)
('biopsies', 8)
('gene', 29)
('studies', 15)
('phase contrast', 2)
('interferon', 8)
('rosenberg', 2)
('highly', 16)
('brl', 2)
('decrease', 71)
('marker', 4)
('apc', 2)
('pigmented', 8)
('total', 14)
('g\\/ml', 20)
('mercaptoethanol', 2)
('use', 78)
('dna', 6)
('positive', 46)
('two', 16)
('almost', 8)
('m2', 4)
('splenocytes', 4)
('more', 47)
('flat', 6)
('0\\%', 20)
('proliferative', 2)
('tail vein', 6)
('lungs', 6)
('ca2\\+', 1)
('novus', 2)
('antigens', 59)
('normalized', 6)
('rabbit', 2)
('tg', 38)
('known', 9)
('sample', 32)
('ma', 707)
('ml', 28)
('mo', 257)
('mn', 4)
('lung metastases', 10)
('incubator', 2)
('bias', 8)
('values', 8)
('morgan', 2)
('metastases', 122)
('inhibitor', 37)
('example', 6)
('10\\%', 6)
('tumor cell', 13)
('control', 52)
('lymph node', 28)
('tap', 2)
('indicated', 4)
('calculation', 2)
('agarose gel', 2)
('cancer center', 6)
('high', 100)
('numbers', 4)
('peptide', 28)
('antigen presentation', 6)
('serum', 10)
('axis', 4)
('socs3', 4)
('mouse', 18)
('discussion', 4)
('immune', 1)
('lesions', 20)
('significance', 6)
('pathway', 4)
('healthy volunteers', 2)
('30 min', 8)
('product', 8)
('lesion', 28)
('outlier', 2)
('fitc', 10)
('clone', 4)
('treatments', 4)
('tissue arrays', 8)
('mab', 4)
('r-', 6)
('invasion', 10)
('data', 41)
('types', 12)
('overexpression', 6)
('t cells', 51)
('st', 766)
('room temperature', 2)
('30 minutes', 4)
('pax3', 44)
('correlation', 2)
('representation', 2)
('retrieval', 2)
('tagged', 2)
('pulsed', 16)
('over', 34)
('vector control', 6)
('primary tumors', 2)
('experiments', 4)
('fetal bovine serum', 2)
('staining', 81)
('visceral', 28)
('proteases', 2)
('priming', 2)
('scoring', 12)
('\\>90', 4)
('group', 16)
('ligand', 1)
('ncbi', 4)
('23', 20)
('pkc activation', 5)
('cd8', 24)
('striking', 10)
('decreases', 33)
('better', 1)
('absence', 6)
('production', 4)
('minute', 6)
('decreased', 12)
('dmso', 2)
('suppressor', 5)
('non', 10)
('remission', 1)
('signaling pathway', 2)
('vitro', 32)
('lymph node metastases', 24)
('therapy', 15)
('effects', 15)
('half', 8)
('not', 91)
('c57bl\\/6', 8)
('detach', 2)
('day', 4)
('paraformaldehyde', 2)
('instructions', 6)
('lineage', 1)
('several', 11)
('progression', 1)
('arrows', 6)
('molecular probes', 4)
('2d', 8)
('slide', 4)
('ifa', 2)
('mrna', 12)
('assay', 46)
('mesenchymal', 2)
('melanomas', 6)
('mean', 2)
('week', 20)
('generation', 2)
('series', 2)
('eg', 114)
('24h', 4)
('t cell', 65)
('fibronectin', 6)
('1d', 4)
('favorable', 2)
('measure', 16)
('melanocytes', 2)
('ev', 215)
('penicillin', 4)
('hla', 12)
('specific antigens', 1)
('matrix', 4)
('3rd', 2)
('plasmids', 2)
('microtiter plate', 6)
('increase', 122)
('mediated', 10)
('health', 4)
('vimentin', 8)
('smh', 2)
('subcutaneous tumor', 4)
('cause', 16)
('viable', 2)
('real time', 4)
('immunohistochemistry', 6)
('linear', 6)
('monoclonal antibodies', 2)
('selection bias', 4)
('free', 4)
('il10', 2)
('tissue array research program', 2)
('imaging', 2)
('hand', 6)
('certified', 2)
('care', 6)
('lymph nodes', 2)
('kiss-1', 1)
('route', 4)
('florida', 2)
('cell culture', 6)
('turn', 8)
('tumor growth', 4)
('routes', 2)
('i-', 28)
('austin', 4)
('south', 2)
('first', 8)
('6 hours', 6)
('student', 2)
('encoding', 6)
('collagen', 2)
('primary', 28)
('one', 25)
('wash', 14)
('western', 12)
('array', 27)
('pmel', 14)
('city', 3)
('publication', 2)
('antigenicity', 1)
('introduction', 1)
('1a', 4)
('regulation', 36)
('1b', 4)
('motility', 15)
('percentage', 3)
('very little', 4)
('observations', 12)
('lipofectamine', 2)
('relationship', 12)
('co-culture', 12)
('cytotoxic t lymphocyte', 1)
('antibodies', 8)
('slides', 2)
('nci', 9)
('part', 2)
('phorbol', 5)
('cultures', 4)
('institution', 4)
('population', 2)
('pigmentation', 2)
('target', 22)
('isolation', 4)
('il6 receptor', 2)
('preparation', 2)
('18s', 6)
('patients', 11)
('treated with', 42)
('f10', 2)
('outcome', 7)
('treated', 76)
('pma', 8)
('pre', 321)
('western blots', 2)
('san', 6)
('hepes', 2)
('lines', 18)
('b16 melanoma', 30)
('30\\%', 2)
('national research council', 2)
('chambers', 2)
('cell surface', 2)
('institutes', 6)
('100\\%', 4)
('efficient', 8)
('transcription', 26)
('mechanism', 1)
('potential', 4)
('academy', 2)
('finding', 2)
('donor', 8)
('subject', 2)
('channel', 4)
('fcs', 4)
('supplementary material', 2)
('normal', 8)
('buffer', 4)
('techniques', 2)
('sfm', 2)
('metastatic lesion', 4)
('significant', 16)
('cap', 14)
('class', 4)
('laboratories', 2)
('observation', 16)
('average', 2)
('disease', 1)
('peptides', 4)
('nuclear', 8)
('sigma', 4)
('corning', 8)
('phenomenon', 4)
('gold', 2)
('accession', 2)
('pkc', 87)
('melanin', 4)
('migration', 2)
('aggressive', 3)
('current', 12)
('ratio', 35)
('stained', 40)
('proportion', 2)
('maturation', 2)
('only', 40)
('hematogenous', 2)
('molecules', 6)
('identification', 2)
('\\/ml', 28)
('\\/mo', 2)
('photographs', 2)
('plate', 10)
('pulmonary metastases', 2)
('dominant', 1)
('silv', 5)
('dependent', 8)
('8 hours', 6)
('glutamine', 4)
('degradation', 2)
('animal models', 2)
('lighter', 4)
('human cell', 4)
('bead', 6)
('recombinant', 6)
('chips', 2)
('untreated', 12)
('secondary', 2)
('biologicals', 2)
('beads', 6)
('mart-1', 286)
('real time pcr', 2)
('tumors', 14)
('summary', 2)
('microscope', 2)
('t cell activation', 8)
('release', 18)
('bars', 4)
('set', 28)
('electroporation', 6)
('metastatic melanoma', 7)
('national', 14)
('cytokine', 6)
('culture', 34)
('sodium azide', 2)
('individual', 6)
('result', 63)
('hla-a2', 8)
('surgery', 4)
('control experiments', 2)
('responses', 1)
('regulator', 4)
('tyrp', 12)
('culture medium', 4)
('subsequent', 9)
('artificial', 4)
('inhibitors', 13)
('il6', 6)
('various', 5)
('1 hour', 6)
('irb', 2)
('signal intensity', 4)
('therapies', 2)
('plasmid', 8)
('saponin', 2)
('ability', 25)
('targeted', 4)
('weak', 17)
('hoffmann-laroche', 2)
('time point', 2)
('stat3', 147)
('reverse', 18)
('similar', 10)
('equal', 28)
('pcr', 10)
('variance', 2)
('expression', 142)
('baltimore', 2)
('co', 495)
('point', 4)
('effective', 2)
('ca', 249)
('sentinel', 4)
('table', 18)
('improvement', 2)
('ct', 378)
('lightly', 2)
('addition', 2)
('three', 9)
('geo', 4)
('extraction', 2)
('initiation', 2)
('pe', 201)
('proposal', 2)
('immunosuppressive effect', 6)
('empty', 6)
('board', 2)
('efficacy', 2)
('fetal calf serum', 2)
('24 hours', 8)
('dissemination', 6)
('two weeks', 4)
('present', 24)
('applied', 2)
('exception', 4)
('statistical analysis', 4)
('il6 signaling', 2)
('ongoing', 2)
('2\\+', 1)
('error', 4)
('sirna', 31)
('drs', 2)
('tyrp1', 10)
('catenin', 4)
('concomitant', 4)
('sox10', 12)
('gel', 6)
('discrepancy', 4)
('tissue', 19)
('il', 143)
('protein', 7)
('technology', 4)
('lymphoblastoid cell line', 2)
('cohort', 46)
('different', 22)
('pax', 46)
('media', 22)
('wound', 16)
('same', 8)
('microarray', 8)
('stimulated', 8)
('patient', 19)
('phenotype', 4)
('subcutaneous', 18)
('units', 4)
('resulting', 2)
('downregulation', 21)
('very small', 1)
('pan', 6)
('higher', 20)
('status', 15)
('transcription factor', 11)
('nih', 4)
('pipette', 2)
('effect', 35)
('kit', 10)
('levels', 51)
('gp100 antibody', 2)
('cell signaling', 4)
('immunofluorescence', 2)
('recent', 3)
('costa', 2)
('supernatant', 6)
('in vitro', 20)
('isotype', 4)
('changes', 5)
('well', 17)
('analysis', 21)
('sodium pyruvate', 2)
('severe', 4)
('materials', 1)
('experimental', 5)
('wnt5a', 577)
('streptomycin', 4)
('dendritic cells', 2)
('colonies', 4)
('protocol', 10)
('less', 37)
('tcr', 18)
('sources', 2)
('50\\%', 4)
('intervals', 2)
('il-10', 2)
('human', 26)
('weekly', 2)
('animal care', 2)
('tables', 2)
('intensity', 8)
('conclusions', 4)
('human cells', 4)
('r\\.', 18)
('treatment', 68)
('invasive', 2)
('5d', 8)
('5a', 583)
('murine', 6)
('increased', 40)
('siah2', 2)
('rna', 67)
('amd', 1)
('increases', 49)
('inhibition', 6)
('loss', 6)
('success', 2)
('signal', 23)
('less than', 14)
('specific', 31)
('monolayer', 4)
('immunosuppressive', 8)
('either', 18)
('dilution', 2)
('reduced', 4)
('el4', 6)
('old', 14)
('methods', 5)
('in vitro assay', 2)
('mhc', 2)
('gel electrophoresis', 2)
('tyrosinase', 1)
('trends', 2)
('growth', 4)
('transfections', 4)
('subtypes', 2)
('nevi', 22)
('il-6r', 2)
('recognition', 1)
('capability', 2)
('flow cytometry', 2)
('scale', 2)
('bottom', 6)
('ice', 67)
('endotoxin', 2)
('tma', 4)
('gene expression', 6)
('melanoma cell', 97)
('bd', 4)
('process', 2)
('data analysis', 2)
('coated', 8)
('2b', 8)
('90\\%', 4)
('post', 6)
('equivalent', 12)
('metastatic', 40)
('mitf', 41)
('dct', 9)
('manufacturer', 10)
('origins', 2)
('island', 4)
('tumor', 48)
('tailed', 2)
('concentrations', 2)
('control group', 4)
('antibody', 16)
('predictor', 2)
('presence', 21)
('washington', 2)
('negative', 28)
('appropriate', 2)
('promise', 2)
('edta', 2)
('mart', 288)
('log', 10)
('support', 8)
('initial', 1)
('immunotherapy', 13)
('clinical', 2)
('low', 90)
('fraction', 2)
('secretion', 2)
('valencia', 2)
('specimens', 2)
('gfp', 8)
('function', 2)
('vehicle', 10)
('expression level', 2)
('histogram', 2)
('sentinel node', 2)
('sustained', 8)
('mice', 54)
('hg', 2)
('fluorescence', 4)
('type', 28)
('cells', 415)
('vivo', 25)
('secrete', 2)
('distribution', 2)
('inoculation', 4)
('pkc epsilon', 2)
('sox10 transcription factor', 4)
('cd44', 10)
('universal', 2)
('metastasis', 20)
('al', 469)
('exogenous', 2)
('general', 4)
('single', 2)
('laboratory', 8)
('statistical significance', 2)
('pkc activity', 4)
('melanoma', 162)
('amounts', 8)
('tip', 2)
('ny', 28)
('iu\\/ml', 4)
('branch', 4)
('test', 14)
('phorbol ester', 5)
('tarp', 4)
('rt', 392)
('transfection', 20)
('il-6', 20)
('variation', 2)
('dr\\.', 4)
('30 minute', 4)
('rule', 2)
('dr', 28)
('time', 16)
('12 hours', 4)
('primary lesion', 6)
('4b', 8)
('4c', 20)
('4a', 8)


total: 868('lymphatic', 4)
('positive control', 6)
('scratch', 10)
('-aaagaccacccggactacaa-', 2)
('n\\=10', 4)
('2 5', 2)
('ice', 67)
('dish', 4)
('primer', 4)
('cytokines', 2)
('animal facility', 2)
('inverse', 13)
('number', 20)
('tx', 4)
('pretreatment', 2)
('young', 2)
('0', 474)
('foster', 2)
('abundant', 2)
('spei', 2)
('tg', 38)
('maryland', 4)
('presentation', 10)
('endogenous', 4)
('cdna', 2)
('confirmation', 2)
('melanoma antigens', 2)
('downstream', 1)
('very', 11)
('activation', 66)
('pigment', 16)
('pathologist', 2)
('cells-1', 1)
('gp75', 1)
('difference', 6)
('anti-mouse', 4)
('condition', 2)
('cultured cells', 4)
('\\%\\ positive', 2)
('pbs', 14)
('level', 55)
('did', 9)
('chains', 6)
('t2', 10)
('solution', 2)
('phosphorylation', 19)
('t-lymphocytes', 2)
('vector', 6)
('-3', 18)
('ml', 28)
('standard deviation', 2)
('3b', 4)
('cell lines', 10)
('serum-free media', 2)
('triplicate', 14)
('trend', 6)
('antigen', 74)
('lack', 2)
('fold', 2)
('microarray analysis', 2)
('enhancement', 1)
('further', 21)
('sterile', 4)
('targets', 13)
('residue', 4)
('tumor-infiltrating', 1)
('\\/a64', 6)
('section', 4)
('melanin', 4)
('current', 12)
('interferon gamma', 4)
('experiment', 11)
('pax3\\.', 4)
('sup', 92)
('monolayer\\.', 4)
('isoforms', 2)
('contrast', 6)
('3d', 4)
('injections', 6)
('cohorts', 20)
('5000', 2)
('national cancer institute', 6)
('genes', 3)
('ulceration', 4)
('hours', 24)
('groups', 6)
('others', 4)
('transcription factors', 3)
('strong', 12)
('cell motility', 6)
('39', 6)
('38', 2)
('tumor-associated', 5)
('study', 12)
('30', 24)
('\\/sup', 4)
('guide', 4)
('janus', 2)
('products', 2)
('activation\\.', 12)
('ctl', 11)
('biopsies', 8)
('gene', 29)
('changes', 5)
('phase contrast', 2)
('interferon', 8)
('rosenberg', 2)
('highly', 16)
('brl', 2)
('decrease', 71)
('marker', 4)
('melanosomal', 27)
('pigmented', 8)
('total', 14)
('dct', 9)
('mercaptoethanol', 2)
('use', 78)
('dna', 6)
('indicated', 4)
('positive', 46)
('negative', 28)
('almost', 8)
('t-cell', 66)
('6', 219)
('tail-vein', 4)
('techniques', 2)
('splenocytes', 4)
('more', 47)
('flat', 6)
('0\\%', 20)
('proliferative', 2)
('tail vein', 6)
('lungs', 6)
('ca2\\+', 1)
('novus', 2)
('antigens', 59)
('normalized', 6)
('rabbit', 2)
('known', 9)
('90', 32)
('high', 100)
('s\\.e\\.m', 4)
('ma', 707)
('\\/ml', 28)
('mo', 257)
('mn', 4)
('lung metastases', 10)
('incubator', 2)
('bias', 8)
('vegf', 4)
('morgan', 2)
('metastases', 122)
('inhibitor', 37)
('example', 6)
('10\\%', 6)
('tumor cell', 13)
('control', 52)
('lymph node', 28)
('tap', 2)
('figure', 164)
('calculation', 2)
('channel', 4)
('agarose gel', 2)
('laboratory\\.', 4)
('cancer center', 6)
('sample', 32)
('tagged', 2)
('numbers', 4)
('dominant', 1)
('antigen presentation', 6)
('serum', 10)
('axis', 4)
('socs3', 4)
('turn', 8)
('technology', 4)
('discussion', 4)
('1', 824)
('immune', 1)
('lesions', 20)
('significance', 6)
('interferon-', 4)
('melanocytic', 2)
('healthy volunteers', 2)
('30 min', 8)
('rhodamine-tagged', 2)
('rwnt5a', 116)
('cytokine', 6)
('outlier', 2)
('fitc', 10)
('clone', 4)
('treatments', 4)
('tissue arrays', 8)
('mab', 4)
('mediated', 10)
('invasion', 10)
('data', 41)
('types', 12)
('a', 7402)
('primers', 4)
('effective', 2)
('lines', 18)
('cd8\\+', 16)
('st', 766)
('room temperature', 2)
('30 minutes', 4)
('m93-047', 12)
('correlation', 2)
('representation', 2)
('first', 8)
('retrieval', 2)
('phospho-stat3', 4)
('pulsed', 16)
('wound', 16)
('over', 34)
('vector control', 6)
('primary tumors', 2)
('experiments', 4)
('fetal bovine serum', 2)
('staining', 81)
('visceral', 28)
('proteases', 2)
('priming', 2)
('-tubulin', 2)
('\\>90', 4)
('27', 84)
('20', 24)
('ligand', 1)
('22', 4)
('23', 20)
('pcr', 10)
('geo', 4)
('striking', 10)
('28', 18)
('decreases', 33)
('better', 1)
('absence', 6)
('production', 4)
('minute', 6)
('decreased', 12)
('dmso', 2)
('suppressor', 5)
('vehicle', 10)
('non', 10)
('remission', 1)
('signaling pathway', 2)
('vitro', 32)
('lymph node metastases', 24)
('cttcagagagaggaagccga', 2)
('effects', 15)
('half', 8)
('not', 91)
('1b', 4)
('detach', 2)
('day', 4)
('paraformaldehyde', 2)
('nci-', 4)
('siah2\\/apc', 2)
('several', 11)
('progression', 1)
('proteins', 2)
('l', 3539)
('molecular probes', 4)
('2d', 8)
('slide', 4)
('ifa', 2)
('mrna', 12)
('assay', 46)
('migration', 2)
('receptor', 10)
('ifn', 8)
('wnt5a-positive', 2)
('tumors', 14)
('melanomas', 6)
('mean', 2)
('week', 20)
('secrete', 2)
('r\\.', 18)
('generation', 2)
('series', 2)
('gfp', 8)
('product', 8)
('t cell', 65)
('fibronectin', 6)
('1d', 4)
('favorable', 2)
('96-well', 8)
('melanocytes', 2)
('ev', 215)
('penicillin', 4)
('hla', 12)
('specific antigens', 1)
('matrix', 4)
('3rd', 2)
('factors', 3)
('30gy', 4)
('t-cells', 38)
('plasmids', 2)
('microtiter plate', 6)
('increase', 122)
('sterile water', 2)
('health', 4)
('vimentin', 8)
('smh', 2)
('subcutaneous tumor', 4)
('melanoma\xe2\x80\x93associated', 1)
('cause', 16)
('viable', 2)
('real time', 4)
('immunohistochemistry', 6)
('pkc-high', 2)
('linear', 6)
('monoclonal antibodies', 2)
('selection bias', 4)
('free', 4)
('tissue array research program', 2)
('imaging', 2)
('hand', 6)
('certified', 2)
('care', 6)
('lymph nodes', 2)
('kiss-1', 1)
('route', 4)
('florida', 2)
('cell culture', 6)
('introduction', 1)
('po4-pkc', 14)
('tumor growth', 4)
('routes', 2)
('r-', 6)
('austin', 4)
('south', 2)
('1000', 4)
('6 hours', 6)
('ability', 25)
('cell signaling', 4)
('encoding', 6)
('igg-fitc', 4)
('collagen', 2)
('primary', 28)
('one', 25)
('wash', 14)
('attccactttgcgttcaagg', 2)
('western', 12)
('array', 27)
('iu\\/ml', 4)
('pmel', 14)
('city', 3)
('publication', 2)
('antigenicity', 1)
('il10', 2)
('1a', 4)
('regulation', 36)
('2', 329)
('motility', 15)
('percentage', 3)
('very little', 4)
('observations', 12)
('-gggaccatggagtggtagc-', 2)
('lipofectamine', 2)
('relationship', 12)
('mechanism', 1)
('co-culture', 12)
('cytotoxic t lymphocyte', 1)
('supernatant', 6)
('promise', 2)
('slides', 2)
('nci', 9)
('larger', 2)
('part', 2)
('phorbol', 5)
('valencia', 2)
('institution', 4)
('population', 2)
('b', 956)
('target', 22)
('16', 92)
('19', 10)
('isolation', 4)
('il6 receptor', 2)
('preparation', 2)
('18s', 6)
('patients', 11)
('r', 4984)
('plasmid', 8)
('matrix-metalloproteinases', 2)
('mel526', 8)
('f10', 2)
('outcome', 7)
('treated', 76)
('pma', 8)
('pre', 321)
('western blots', 2)
('san', 6)
('hepes', 2)
('t cells', 51)
('ncbi', 4)
('b16 melanoma', 30)
('uacc-1273ev', 2)
('rat', 110)
('30\\%', 2)
('dendritic', 2)
('plate\\.', 2)
('cell surface', 2)
('institutes', 6)
('gp100-pulsed', 4)
('sodium pyruvate', 2)
('transcription', 26)
('il-10', 2)
('elisa', 8)
('potential', 4)
('biotinylated', 2)
('academy', 2)
('finding', 2)
('donor', 8)
('subject', 2)
('m2', 4)
('200', 12)
('fcs', 4)
('pax3', 44)
('supplementary material', 2)
('normal', 8)
('buffer', 4)
('overexpression', 6)
('edta', 2)
('catenin', 4)
('electroporation', 6)
('sfm', 2)
('metastatic lesion', 4)
('significant', 16)
('70', 6)
('cap', 14)
('class', 4)
('laboratories', 2)
('observation', 16)
('average', 2)
('flow', 2)
('disease', 1)
('electroporated', 8)
('peptides', 4)
('nuclear', 8)
('sigma', 4)
('corning', 8)
('phenomenon', 4)
('gold', 2)
('gp100 antibody', 2)
('accession', 2)
('pkc', 87)
('hla-a2-fitc', 2)
('expression\\.', 26)
('aggressive', 3)
('mice', 54)
('cell', 489)
('ratio', 35)
('stained', 40)
('proportion', 2)
('uacc903', 28)
('hg', 2)
('maturation', 2)
('only', 40)
('hematogenous', 2)
('molecules', 6)
('factor', 11)
('identification', 2)
('metastases\\.', 16)
('\\/mo', 2)
('photographs', 2)
('plate', 10)
('pulmonary metastases', 2)
('release\\.', 4)
('phospho-stat3tyr705', 2)
('silv', 5)
('dependent', 8)
('8 hours', 6)
('1 hour', 6)
('dc', 11)
('degradation', 2)
('animal models', 2)
('lighter', 4)
('human cell', 4)
('bead', 6)
('recombinant', 6)
('cd8', 24)
('untreated', 12)
('secondary', 2)
('biologicals', 2)
('beads', 6)
('mart-1', 286)
('real time pcr', 2)
('uacc647', 18)
('summary', 2)
('microscope', 2)
('-catenin', 4)
('-gagctgaagcattgaagcaa', 2)
('release', 18)
('bars', 4)
('set', 28)
('4\xe2\x80\x937', 2)
('saponin', 2)
('metastatic melanoma', 7)
('national', 14)
('ncbi\xe2\x80\x99s', 2)
('potent', 5)
('culture', 34)
('sodium azide', 2)
('proliferation', 1)
('result', 63)
('hla-a2', 8)
('surgery', 4)
('control experiments', 2)
('responses', 1)
('regulator', 4)
('tyrp', 12)
('culture medium', 4)
('mart1', 2)
('subsequent', 9)
('artificial', 4)
('inhibitors', 13)
('il6', 6)
('3', 487)
('various', 5)
('glutamine', 4)
('irb', 2)
('signal intensity', 4)
('therapies', 2)
('treated with', 42)
('24', 18)
('-ccatctgtgcagcaaacaac-', 2)
('assays', 28)
('tables', 2)
('targeted', 4)
('weak', 17)
('lymphocyte', 8)
('lesion', 28)
('wnt5a-low', 27)
('hoffmann-laroche', 2)
('group', 16)
('uacc1273', 50)
('time point', 2)
('stat3', 147)
('reverse', 18)
('similar', 10)
('equal', 28)
('wnt5a-high', 30)
('pkc activation', 5)
('figures', 6)
('irradiated', 4)
('variance', 2)
('expression', 142)
('baltimore', 2)
('c57bl\\/6', 8)
('co', 495)
('point', 4)
('invasive', 2)
('ca', 249)
('rwnt5a-treated', 14)
('pathway', 4)
('-ttgccgaagtcgatgtga-3', 2)
('sentinel', 4)
('table', 18)
('pulmonary', 2)
('improvement', 2)
('ct', 378)
('lightly', 2)
('addition', 2)
('rhodamine', 4)
('three', 9)
('mart', 288)
('extraction', 2)
('much', 10)
('initiation', 2)
('kinases', 2)
('pe', 201)
('proposal', 2)
('immunosuppressive effect', 6)
('monoclonal', 2)
('board', 2)
('efficacy', 2)
('fetal calf serum', 2)
('thyrocytes', 2)
('24 hours', 8)
('great', 16)
('dissemination', 6)
('mesenchymal', 2)
('5d', 8)
('two weeks', 4)
('present', 24)
('applied', 2)
('cytotoxic', 1)
('exception', 4)
('biopolymer', 2)
('statistical analysis', 4)
('il6 signaling', 2)
('rpmi', 6)
('institute', 14)
('serine727', 6)
('ongoing', 2)
('2\\+', 1)
('error', 4)
('pkc-low', 2)
('sirna', 31)
('drs', 2)
('national research council', 2)
('tyrp1', 10)
('cd8-pe', 2)
('concomitant', 4)
('sox10', 12)
('pigmentation', 2)
('gel', 6)
('discrepancy', 4)
('ivt', 4)
('tissue', 19)
('sentinel lymph node', 2)
('il', 143)
('chambers', 2)
('protein', 7)
('mouse', 18)
('lymphoblastoid cell line', 2)
('cohort', 46)
('different', 22)
('pax', 46)
('media', 22)
('b16-f10', 2)
('-gcagagaggctgtgctccta-3', 2)
('cytometry', 2)
('same', 8)
('microarray', 8)
('stimulated', 8)
('patient', 19)
('phenotype', 4)
('subcutaneous', 18)
('units', 4)
('resulting', 2)
('downregulation', 21)
('very small', 1)
('pan', 6)
('higher', 20)
('status', 15)
('transcription factor', 11)
('nih', 4)
('pipette', 2)
('effect', 35)
('kit', 10)
('levels', 51)
('i-', 28)
('student', 2)
('scoring', 12)
('immunofluorescence', 2)
('recent', 3)
('costa', 2)
('antibodies', 8)
('in vitro', 20)
('i', 5499)
('studies', 15)
('well', 17)
('analysis', 21)
('efficient', 8)
('severe', 4)
('materials', 1)
('experimental', 5)
('therapy', 15)
('wnt5a', 577)
('streptomycin', 4)
('dendritic cells', 2)
('colonies', 4)
('protocol', 10)
('less', 37)
('tcr', 18)
('cohorts\\.', 2)
('sources', 2)
('50\\%', 4)
('intervals', 2)
('lymphoblastoid', 2)
('human', 26)
('differentiation', 2)
('uacc1273ev', 26)
('weekly', 2)
('animal care', 2)
('b16', 74)
('intensity', 8)
('conclusions', 4)
('\\>', 12)
('\\?', 156)
('\\:', 64)
('human cells', 4)
('\\%', 98)
('treatment', 68)
('lymphocytes', 7)
('\\/', 78)
('instructions', 6)
('5a', 583)
('\\(', 552)
('\\)', 622)
('murine', 6)
('lineage', 1)
('increased', 40)
('siah2', 2)
('rna', 67)
('amd', 1)
('increases', 49)
('antigen-specific', 2)
('loss', 6)
('success', 2)
('signal', 23)
('less than', 14)
('specific', 31)
('monolayer', 4)
('immunosuppressive', 8)
('t', 7556)
('dilution', 2)
('reduced', 4)
('el4', 6)
('old', 14)
('methods', 5)
('in vitro assay', 2)
('arrows', 6)
('mhc', 2)
('supplementary', 44)
('tyrosinase', 1)
('trends', 2)
('growth', 4)
('transfections', 4)
('t cell activation', 8)
('apc', 2)
('subtypes', 2)
('nevi', 22)
('il-6r', 2)
('recognition', 1)
('medium\\.', 2)
('24h', 4)
('capability', 2)
('flow cytometry', 2)
('scale', 2)
('icn', 2)
('bottom', 6)
('gp100-specific', 4)
('inhibition', 6)
('endotoxin', 2)
('chips', 2)
('tma', 4)
('gene expression', 6)
('melanoma cell', 97)
('either', 18)
('bd', 4)
('process', 2)
('data analysis', 2)
('coated', 8)
('2b', 8)
('90\\%', 4)
('post', 6)
('equivalent', 12)
('metastatic', 40)
('variation', 2)
('mitf', 41)
('g\\/ml', 20)
('manufacturer', 10)
('peptide', 28)
('isotype', 4)
('origins', 2)
('island', 4)
('tumor', 48)
('gp10025\xe2\x80\x9333', 4)
('tailed', 2)
('concentrations', 2)
('control group', 4)
('antibody', 16)
('predictor', 2)
('gamma', 4)
('tyrp-1', 2)
('presence', 21)
('washington', 2)
('two', 16)
('-cgctggctcttaaggtgaat-3', 2)
('appropriate', 2)
('anti-cd3', 2)
('lung', 16)
('capped', 10)
('non-canonical', 2)
('cells\\.', 30)
('4\\\xc2\\\xb0c\\.', 2)
('log', 10)
('lower', 15)
('support', 8)
('initial', 1)
('immunotherapy', 13)
('cultured', 24)
('clinical', 2)
('low', 90)
('fraction', 2)
('secretion', 2)
('cultures', 4)
('specimens', 2)
('eg', 114)
('function', 2)
('epsilon', 2)
('pbs-t', 2)
('-taagcccaggagttgctttg-', 2)
('histogram', 2)
('sentinel node', 2)
('wnt', 579)
('lymph', 42)
('sustained', 8)
('line', 31)
('mart\\-1\\.', 25)
('gel electrophoresis', 2)
('fluorescence', 4)
('expression level', 2)
('type', 28)
('cells', 415)
('4\\.', 4)
('vivo', 25)
('cutaneous', 20)
('2\xc3\x97105', 8)
('empty', 6)
('distribution', 2)
('inoculation', 4)
('pkc epsilon', 2)
('sox10 transcription factor', 4)
('gp100', 59)
('associated', 17)
('cd44', 10)
('universal', 2)
('measure', 16)
('metastasis', 20)
('al', 469)
('exogenous', 2)
('general', 4)
('continued', 4)
('single', 2)
('laboratory', 8)
('statistical significance', 2)
('pkc activity', 4)
('melanoma', 162)
('amounts', 8)
('fixing', 2)
('44', 22)
('45', 10)
('tip', 2)
('43', 6)
('igg', 10)
('ny', 28)
('5', 785)
('branch', 4)
('test', 14)
('phorbol ester', 5)
('tarp', 4)
('node', 30)
('rt', 392)
('transfection', 20)
('ctls', 2)
('il-6', 20)
('not\\.', 2)
('il-2', 4)
('dr\\.', 4)
('stat3\\.', 2)
('individual', 6)
('30 minute', 4)
('values', 8)
('realtime', 2)
('rule', 2)
('dr', 28)
('time', 16)
('12 hours', 4)
('100\\%', 4)
('primary lesion', 6)
('4a', 8)
('4b', 8)
('4c', 20)
('anti-cd28', 2)
